KR20110114195A - Pet hydrogel patch mixed with inorganic materials and its manufacturing method - Google Patents
Pet hydrogel patch mixed with inorganic materials and its manufacturing method Download PDFInfo
- Publication number
- KR20110114195A KR20110114195A KR1020100033697A KR20100033697A KR20110114195A KR 20110114195 A KR20110114195 A KR 20110114195A KR 1020100033697 A KR1020100033697 A KR 1020100033697A KR 20100033697 A KR20100033697 A KR 20100033697A KR 20110114195 A KR20110114195 A KR 20110114195A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- hydrogel
- inorganic material
- pet
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 57
- 229910010272 inorganic material Inorganic materials 0.000 title claims abstract description 43
- 239000011147 inorganic material Substances 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 230000008014 freezing Effects 0.000 claims description 5
- 238000010257 thawing Methods 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 240000007124 Brassica oleracea Species 0.000 claims description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 244000042664 Matricaria chamomilla Species 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 235000019198 oils Nutrition 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 229920005615 natural polymer Polymers 0.000 claims description 3
- -1 pulloteoglucan Polymers 0.000 claims description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 235000019489 Almond oil Nutrition 0.000 claims description 2
- 241001116389 Aloe Species 0.000 claims description 2
- 240000007087 Apium graveolens Species 0.000 claims description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 2
- 235000010591 Appio Nutrition 0.000 claims description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 2
- 240000006891 Artemisia vulgaris Species 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 2
- 235000015655 Crocus sativus Nutrition 0.000 claims description 2
- 244000124209 Crocus sativus Species 0.000 claims description 2
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 2
- 244000008991 Curcuma longa Species 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 102000016942 Elastin Human genes 0.000 claims description 2
- 108010014258 Elastin Proteins 0.000 claims description 2
- 108010022355 Fibroins Proteins 0.000 claims description 2
- 229920000926 Galactomannan Polymers 0.000 claims description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 2
- 240000008397 Ganoderma lucidum Species 0.000 claims description 2
- 240000001972 Gardenia jasminoides Species 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920002581 Glucomannan Polymers 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 240000008669 Hedera helix Species 0.000 claims description 2
- 244000208060 Lawsonia inermis Species 0.000 claims description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 2
- 240000007472 Leucaena leucocephala Species 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 2
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 2
- 235000017945 Matricaria Nutrition 0.000 claims description 2
- 102000014171 Milk Proteins Human genes 0.000 claims description 2
- 108010011756 Milk Proteins Proteins 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 241000237502 Ostreidae Species 0.000 claims description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims description 2
- 235000002789 Panax ginseng Nutrition 0.000 claims description 2
- 240000004371 Panax ginseng Species 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 244000062780 Petroselinum sativum Species 0.000 claims description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 241000508269 Psidium Species 0.000 claims description 2
- 229920001218 Pullulan Polymers 0.000 claims description 2
- 239000004373 Pullulan Substances 0.000 claims description 2
- 241000220317 Rosa Species 0.000 claims description 2
- 108010013296 Sericins Proteins 0.000 claims description 2
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 235000011399 aloe vera Nutrition 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims description 2
- 235000001014 amino acid Nutrition 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 229910052980 cadmium sulfide Inorganic materials 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000003373 curcuma longa Nutrition 0.000 claims description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920002549 elastin Polymers 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 229940046240 glucomannan Drugs 0.000 claims description 2
- 235000002532 grape seed extract Nutrition 0.000 claims description 2
- 229940087603 grape seed extract Drugs 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 150000001261 hydroxy acids Chemical class 0.000 claims description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004705 kojic acid Drugs 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- 235000021239 milk protein Nutrition 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- 239000010466 nut oil Substances 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 235000020636 oyster Nutrition 0.000 claims description 2
- 235000011197 perejil Nutrition 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 2
- 235000019423 pullulan Nutrition 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 235000013974 saffron Nutrition 0.000 claims description 2
- 239000004248 saffron Substances 0.000 claims description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
- 229940031439 squalene Drugs 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 235000013976 turmeric Nutrition 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 150000003700 vitamin C derivatives Chemical class 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc oxide Inorganic materials [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 44
- 208000027418 Wounds and injury Diseases 0.000 abstract description 44
- 241000894006 Bacteria Species 0.000 abstract description 15
- 230000029663 wound healing Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003796 beauty Effects 0.000 abstract description 9
- 231100000241 scar Toxicity 0.000 abstract description 9
- 230000003370 grooming effect Effects 0.000 abstract description 7
- 208000032544 Cicatrix Diseases 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 6
- 230000037387 scars Effects 0.000 abstract description 6
- 238000009472 formulation Methods 0.000 abstract description 3
- 239000000499 gel Substances 0.000 abstract description 3
- 206010072170 Skin wound Diseases 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 2
- 208000003322 Coinfection Diseases 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 16
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000000416 hydrocolloid Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 229920005830 Polyurethane Foam Polymers 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000008952 bacterial invasion Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000002121 nanofiber Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000011496 polyurethane foam Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000005911 anti-cytotoxic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000010393 epithelial cell migration Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 외부 환경 조건에 용해가 가능한 무기재료가 혼입된 애완용 하이드로겔 패치에 관한 것으로, 유효한 성분을 애완용 동물 용품에 획기적으로 부여하며 동시에 일정 시간 동안 지속적으로 애완동물에게 전달 가능한 무기재료가 혼입된 하이드로겔 패치는 외부의 물리적 힘으로부터 피부의 상처 및 트러블을 완화시켜주는 효과와 더불어 세균과 이물질의 침투를 방지할 수 있는 것을 특징으로 하는 애완견용 하이드로겔 패치이다.
본 발명은 피부에 접착 시 용해가 가능한 겔을 사용하여 애완용 동물의 상처 치유를 촉진 시키고, 상처 발생 전 상태로 되돌려서 상처로 인한 아픔을 줄임과 동시에 심한 흉터가 생기는 것을 방지하며, 오랫동안 자외선 및 외부 환경의 영향을 받아 손상된 부위를 회복시킨다. 본 발명의 목적은 상처치유 과정에서 피부 재생을 가급적 빠르게 하여 흉터 및 2차 감염의 발생을 억제하는 효과가 있는 무기재료 및 상처 치료제, 피부에 도움을 주는 제제를 겔에 포함하여 피부 접착 시 유효한 성분이 혼입된 하이드로겔이 완전히 용해되어 애완용 동물의 피부로 침투되는 하이드로겔 패치를 개발하는 것이다.
본 발명은 피부 접착 시 용해가 가능한 무기재료가 혼입된 하이드로겔 패치로서 상처 치료 및 애완견 미용에 획기적으로 응용 가능한 제제의 형태로 세부적으로는 상처치료, 미용, 흉터제거, 밴드 등에 이용될 수 있는 피부 접착 시 용해가 가능한 무기재료가 혼입된 하이드로겔 패치에 관한 것이다. The present invention relates to a pet hydrogel patch containing an inorganic material that can be dissolved in external environmental conditions. The present invention provides an effective ingredient to a pet product, and at the same time, an inorganic material that can be continuously delivered to a pet for a predetermined time is mixed. Hydrogel patch is a dog hydrogel patch, characterized in that to prevent the penetration of bacteria and foreign substances with the effect of alleviating skin wounds and troubles from the external physical force.
The present invention promotes wound healing of pet animals by using a gel that is soluble when adhered to the skin, reduces the pain caused by the wound by returning to the state before the wound, and prevents the occurrence of severe scars for a long time. Recover damaged areas under environmental influences. An object of the present invention includes an inorganic material that has the effect of inhibiting the occurrence of scars and secondary infections by making the skin regenerate as fast as possible during wound healing, an agent for treating the skin, and an agent that helps the skin in the gel and is effective for skin adhesion. The entrained hydrogel is completely dissolved to develop a hydrogel patch that penetrates into the skin of a pet animal.
The present invention is a hydrogel patch incorporating a dissolvable inorganic material when the skin is adhered in the form of a formulation that can be innovatively applied to wound healing and pet grooming, in detail, the skin that can be used for wound treatment, beauty, scar removal, band, etc. The present invention relates to a hydrogel patch containing an inorganic material that can be dissolved during adhesion.
Description
본 발명은 외부의 영향에 따라 용해되는 무기재료가 혼입된 애완용 하이드로겔 패치 조성물 및 그 제조방법에 관한 것으로, 애완견 피부에 접착 시 하이드로겔 조성물이 용해가 되어 상처 치유 및 미용에 효과적으로 적용 될 수 있는 하이드로겔 패치 조성물 및 그 제조 방법에 관한 것이다. The present invention relates to a pet hydrogel patch composition and a method for manufacturing the same mixed with an inorganic material dissolved according to the external influence, the hydrogel composition can be effectively applied to wound healing and beauty when adhered to the skin of dogs It relates to a hydrogel patch composition and a method for producing the same.
애완용 동물의 피부는 외부 자극으로부터 애완동물의 몸을 보호하며 수분의 손실을 막아주고 체온조절 및 세균 침입 방지 등 중요한 생명보호기능을 수행하는 장기의 하나로서, 화상이나 각종 외상에 의해 피부가 손상되면 본래의 기능을 상실하는 결과를 초래하게 되고, 수분 손실 등에 따라 여러 가지 부작용과 외부로부터 세균 감염 등을 발생시켜 환부의 치료를 어렵게 하거나 2차적인 기능장애 또는 손상과 같은 추가적인 부작용들이 나타나 심한 경우에는 생명연장에도 영향을 미치게 된다. 따라서 상처의 치료를 신속하게 하고 2차적인 각종 부작용을 최소화하기 위해서는 적절한 드레싱재를 이용한 상처 치료가 필수적이다. 동물의 피부는 고운 다습한 날씨에 노출 되게 되면 피부 자체의 보호력이 약해지게 된다. 이로 인해 피지 등의 피부 분비물들이 많아지며 피부가 늘어지고 자외선에 의한 피부자극이 발생한다. 그래서 애완견도 이에 대한 적절한 피부 관리가 필요하다. 우선, 피지 등의 피부 분비물이 생기면, 즉시 닦아주고 가능한 한 자주 씻어서 청결감과 청량감을 유지해야 한다. 그러나 애완견을 자주 씻기게 되면 피부의 수분 손실이 발생하여 피부가 건조하고 거칠어지기 쉬우므로 피부 분비물의 흡수와 수분 공급을 동시에 만족시키는 피부 관리가 요구된다. 또한, 동물의 피부를 덮고 있는 모(털)가 비위생적으로 관리될 경우 애완동물을 키우는 사람들의 위생에도 문제점이 야기될 수 있다. 따라서 애완동물의 모를 위생적으로 관리해주고 흡수성이 있어 피부 분비물을 흡수 제거할 수 있고, 수분 함량이 많아 피부에 수분 공급을 할 수 있는 제품의 개발이 필요하다. The skin of a pet animal is one of the organs that protects the pet's body from external stimuli, prevents the loss of water, and performs important life protection functions such as controlling the body temperature and preventing bacterial invasion. It causes the loss of its original function, and it causes various side effects and bacterial infection from the outside due to water loss, making it difficult to treat the affected area, or additional side effects such as secondary dysfunction or damage are severe. It also affects life extension. Therefore, in order to quickly heal wounds and to minimize secondary side effects, it is necessary to use wound dressings. When the skin of an animal is exposed to fine humid weather, the protection of the skin itself becomes weak. This causes a lot of skin secretions, such as sebum, the skin is stretched and the skin irritation caused by ultraviolet rays. So dogs need proper skin care. First, if you have sebum or other skin secretions, you should wipe them off immediately and wash them as often as possible to keep them clean and refreshed. However, if dogs are washed frequently, the skin loses moisture, which makes the skin dry and rough, so skin care is required to satisfy the absorption and supply of skin secretions. In addition, if the hair (hair) covering the skin of the animal is unsanitary care can also cause problems in the hygiene of people raising pets. Therefore, it is necessary to develop a product that can hygienically manage the hair of a pet and can absorb and remove skin secretions due to its absorbency.
애완동물의 모를 위생적으로 관리해주고 상처치유 및 피부 트러블을 관리하기 위해 무기재료가 혼입된 하이드로겔의 사용은 그 속에 함유되어 있는 무기재료 및 미용제가 다량으로 신속하게 하이드로겔에서 부터 피부로 전달 될 수 있어야 한다. 이와 같은 특성을 만족시키기 위해서는 종래의 것에 비하여 하이드로겔 속의 치유제 및 미용제가 피부 속으로 신속하고 고르게 전달되는 특징을 가져야 한다. 미국특허 제6,051,425호는 동결건조로 제조된 다공성의 콜라겐 드레싱 시트 재료의 제조를 기술하고 있다. 상기 기술들은 동물 콜라겐을 이용해야 하므로 제조과정에서 비용이 많이 들어 매우 고가로 시판되고 있으며, 수화된 콜라겐 젤을 이용하므로 경도가 낮은 문제점이 있다. 또한 동결건조 방식은 에너지 소모가 크고 시간이 오래 걸리는 단점도 가지고 있다. The use of hydrogels mixed with inorganic materials to sanitize pet hair hygienically and to manage wound healing and skin problems can result in the rapid delivery of large amounts of inorganic materials and cosmetics from the hydrogels to the skin. Should be In order to satisfy such characteristics, the healing agent and the cosmetic agent in the hydrogel should be quickly and evenly delivered to the skin as compared with the conventional one. U. S. Patent No. 6,051, 425 describes the preparation of porous collagen dressing sheet materials made by lyophilization. Since the above techniques are required to use animal collagen, it is very expensive due to the high cost in the manufacturing process, and there is a problem of low hardness because it uses hydrated collagen gel. In addition, the freeze-drying method has the disadvantage of high energy consumption and long time.
상처 치료용으로 사용되는 하이드로겔 중에서 미국특허 제 5,501,661 및 5,489,262호에 제시된 하이드로겔 형은 투과성이 없는 고분자 필름층에 하이드로겔이 도포된 형태를 이루고 있고, 고분자 필름층은 하이드로겔이 탈수되거나 건조되는 것을 막으며, 하이드로겔층은 상처 면에 접하여 삼출액을 흡수하고 습윤 환경을 유지하여 상처치료를 촉진시킨다. 그러나 낮은 투습도로 인해 삼출액이 많은 상처에는 사용이 불가능하고 수팽윤 상태가 지속되면 드레싱재가 붕괴되어 정상 피부에 트러블을 일으키는 등의 단점을 가진다. 미국특허 제 5,445,604 및 5,065,752호에서 제시된 친수성 폴리우레탄 폼 드레싱제는 그 구조가 폴리우레탄 폼의 양면에 필름을 라이네이션 시킨 형태로, 상처 면에 접하는 필름에는 미세구멍이 기계적으로 뚫어져 있지 않은 바깥쪽 필름의 투습도가 충분치 못하기 때문에 장기간 부착에는 적합지 못하다는 문제점이 있고, 상처면 쪽 필름에 존재하는 구멍으로 인하여 재생조직이 부착되는 등의 문제점이 있다. Among the hydrogels used for wound treatment, the hydrogel types shown in US Pat. Nos. 5,501,661 and 5,489,262 form a form in which a hydrogel is applied to a polymer film layer having no permeability, and the polymer film layer is dehydrated or dried. The hydrogel layer absorbs the exudates in contact with the wound and maintains a moist environment to promote wound healing. However, due to low moisture permeability, it is impossible to use a wound with many exudates, and if the water swelling state continues, the dressing material collapses and causes troubles on the normal skin. The hydrophilic polyurethane foam dressing agent shown in U.S. Patent Nos. 5,445,604 and 5,065,752 is a structure in which the structure is lined with a film on both sides of the polyurethane foam, and the outer film is not mechanically perforated in the film contacting the wound surface. Since the moisture permeability is not sufficient, there is a problem that it is not suitable for long-term adhesion, there is a problem such that the regeneration tissue is attached due to the holes present in the film on the wound surface.
일반적으로 창상, 외상 등과 같은 피부의 상처를 효과적으로 치료하기 위해서 드레싱(Wound dressing)을 사용한다. 상처 치료용 드레싱이 가져야 할 특성으로는 상처와 접촉면에서 적당한 습기의 유지능력이 필요하고, 상처 분비물의 조절 능력, 상처에 대한 드레싱의 부착 및 제거의 용이성, 외부의 상처부위 간 공기 및 수증기 관통성, 외부에 대한 상처 부위의 단열성, 박테리아의 침입에 대한 저항성, 피부에 대한 무독성, 우수한 기계적 물성 등이 요구된다. 이러한 드레싱제의 발전은 건조 드레싱을 주류로 발전되어 왔으나, 근래에 와서 건조드레싱을 대신하는 습윤 드레싱의 혁명적인 이론 발전은 몇 개 중요한 연구 결과에 의하여 발전 되고 있다. Hinman과 Maibach은 상처부위에서 습기가 상처 치유에 미치는 효과에 대한 이론을 확립하였으며, 1970년경에 Michael 등은(Michael Z. C., Hu and Mark Reeves, Biosorption of Uranium by Pseud omonas Aeruginosa strain CUS Immobilized in a Novel Matrix Biotechnology Progress, 13(1), 1997) 상처부위에서 작당한 수분을 함유하고 상피세포의 이동이 활발하고, 상처치유 기간이 단축됨을 밝혔다. 특히 Winter는 상피 재형성이 상처 부위가 건조된 상태보다 적당한 수분을 함유한 상태에서 40%정도 빠른 효과를 나타낸다고 실험을 통하여 증명하였다. 이러한 습윤환경이론을 충족시키는 최초의 드레싱제로서 근대 드레싱의 제 1세대는 1971년 Smith Nephew사(社)의 Opsite란 상품이 출시되었으며 이것은 Polyurethane 필름과 vinyl ether, 점착제로 구성된 것으로 창상 밖으로부터 세균과 수분의 진입을 막고, 창상면으로부터 가스와 수증기의 투과를 일정하게 허용하여 창상주위 피부가 물러지지 않고 창상면에 세균감염이 생기지 않도록 방어하며 습윤 환경을 유지시키는 반투과성 필름 드레싱이다. 이러한 이론을 근거로 출시된 Opsite는 습윤 환경이론을 만족시키는 우수한 드레싱제로 널리 사용되었지만 그 성질과 점착성 등의 문제점들이 드러나기도 했다. 다른 제조 회사에서 필름으로 사용된 소재의 개량과 점착제의 아크릴레이트로의 변경을 시도한 다양한 소재들을 개발하였으며 이러한 발전은 1970년대 소위 2세대의 드레싱제들이 출연되었다. Convatec사(社)의 하이드로 콜로이드(Hydro colloid)를 사용한 제품으로 하이드로 콜로이드제는 친수성 폴리머를 주성분으로 하는 일련의 제품을 속칭하는 것으로 창상, 스토머(stoma) 및 실금 관리기구에 광범위하게 쓰이는 용어다. 하이드로 콜로이드제의 출현은 창상치유, 특히 욕창, 하퇴궤양 등의 만성 난치성 피부궤양의 치료에 획기적인 도움을 주었다. 이들 드레싱은 단순히 상처만 덮고 상처분비물을 흡수하는 단계에 그치지 않고 적당한 수분을 함유하여 상피 재형성을 돕고 박테리아 침입을 막는 등 다양한 방면으로 연구가 진행되고 있다. In general, dressing is used to effectively treat wounds of the skin such as wounds and traumas. Wound dressings require the ability to maintain adequate moisture at the contact surface with wounds, the ability to control wound secretions, ease of attachment and removal of dressings to wounds, and air and vapor permeability between external wounds. Insulation of the wound to the outside, resistance to the invasion of bacteria, non-toxic to the skin, excellent mechanical properties are required. The development of such dressing agents has been developed into the mainstream of dry dressing, but the revolutionary theoretical development of wet dressing instead of dry dressing has been developed by some important research results. Hinman and Maibach established a theory of the effect of moisture on wound healing, and by 1970 Michael et al. (Michael ZC, Hu and Mark Reeves, Biosorption of Uranium by Pseud omonas Aeruginosa strain CUS Immobilized in a Novel Matrix Biotechnology Progress, 13 (1), 1997) It contained a moderate amount of water in the wound, active epithelial cell migration, and shortened wound healing period. In particular, Winter proved that epithelial remodeling was about 40% faster in the presence of adequate moisture than in the wound. As the first dressing agent to meet this theory of wet environment, the first generation of modern dressings was launched in 1971 by Opportunity, Smith Nephew, which consists of polyurethane film, vinyl ether and adhesive. It is a semi-permeable film dressing that prevents the ingress of moisture and allows the permeation of gas and water vapor from the wound surface to prevent the skin around the wound from falling down and to prevent bacterial infection on the wound surface and to maintain a wet environment. Based on this theory, Opsite was widely used as an excellent dressing agent that satisfies the theory of wet environment, but its problems such as its properties and tackiness were revealed. Other manufacturers have developed a variety of materials that have attempted to improve the materials used for films and to change the pressure-sensitive adhesives to acrylates. This development resulted in the so-called second-generation dressings in the 1970s. A product using Convatec's Hydro colloid, a hydrocolloid is a generic term for a series of products based on hydrophilic polymers and is widely used in wound, stoma and incontinence management devices. . The emergence of hydrocolloids has helped significantly in the treatment of wound healing, especially chronic refractory skin ulcers such as pressure sores and lower ulcers. These dressings are not just covering the wounds and absorbing the secretions, but are being studied in various ways, including proper moisture to help remodel epithelium and prevent bacterial invasion.
약물 전달 시스템(Drug Delivery System, DDS)에 대한 연구로 Zeng 및 Aeng (J. Control, Release, 92, 227(2003)) 등은 생분해성 원료인 poly(L-lactic acid) (PLA)에 약물을 혼입하고 전기방사하여 나노섬유를 제조한 후 약물의 방출 특성을 평가 하였는데, 약물의 방출은 나노섬유 내부에서 약물의 확산이나 투과에 의존하지 않고 단지 담체인 고분자섬유의 분해에 영향을 받는다. 이처럼 PLA를 분해시키는 proteinase K의 존재 유무에 따라 약물의 방출이 결정되며 의료용 산업에서 연구 및 산업화에 대한 노력이 이루어지고 있다. In the study of drug delivery system (DDS), Zeng and Aeng (J. Control, Release, 92, 227 (2003)) have applied drugs to biodegradable poly (L-lactic acid) (PLA). After the nanofibers were prepared by incorporation and electrospinning, the release properties of the drug were evaluated. The release of the drug was not influenced by the diffusion or permeation of the drug inside the nanofibers, but only by the decomposition of the polymer fiber as a carrier. As such, the release of drugs is determined by the presence of proteinase K, which degrades PLA, and research and industrialization efforts are being made in the medical industry.
일반적으로 애완동물의 미용과 피부 상처를 치료할 때는 적용부위에 장시간 보호구(protection device)를 붙이기가 어렵다. 특히 대부분의 애완동물의 경우 털이 있으므로 상처 및 피부 트러블이 발생할 경우 드레싱제를 피부에 직접적으로 붙여줄 수 없다. 이러한 효과를 증진시키기 위하여 은나노, 금나노 및 습윤흡수시 팽윤되는 성질이 있는 점토(clay) 등의 무기재료가 혼입된 수용성 고분자 하이드로겔 패치가 개발된다면 애완동물의 상처치유 및 피부 트러블을 효과적으로 관리할 수 있다. 특히 모의 위생상태를 관리할 수 있는 약제 등이 함유되어 있다면 효과적일 수 있다. 이러한 애완동물용 하이드로겔 패치는 피부 사이의 친화성을 높이고 모를 위생적으로 관리할 수 있는 약제들이 함유되고, 특히 무기재료 및 미용제 또는 약물이 용해되면서 약물이 피부로 전달되고, 무기재료의 특성에 맞는 항균 및 피부의 온도 조절에 결정적으로 영향을 미치게 된다면 애완동물의 피부관리에 아주 효과적일 수 있다. 즉 피부와 친화성이 큰 무기재료가 혼입된 하이드로겔 패치에서 애완견 피부로 미용제 또는 약물의 전달이 용이하고 신속하게 일어날 수 있게 된다.
In general, it is difficult to attach a protection device for a long time to the beauty of the pet and to treat skin wounds. In particular, most pets are hairy, so if a wound or skin trouble occurs, the dressing agent cannot be applied directly to the skin. To enhance this effect, water-soluble polymer hydrogel patches containing inorganic materials such as silver nano, gold nano and clay that swell during wet absorption can be developed to effectively manage wound healing and skin troubles of pets. Can be. In particular, it may be effective if it contains a drug that can manage the simulated hygiene. These pet hydrogel patches contain drugs that can enhance affinity between skin and hygienically manage hair, especially when inorganic materials and cosmetics or drugs are dissolved, drugs are delivered to the skin, and the characteristics of inorganic materials Determining the correct antibacterial and temperature control of the skin can be very effective for pet skin care. That is, in the hydrogel patch containing an inorganic material having a high affinity for skin, the delivery of a cosmetic or drug to the skin of a dog can occur easily and quickly.
이에 본 발명의 무기재료가 혼입된 애완동물용 하이드로겔 패치는 서서히 용해가 가능하여 미용제 및 약물이 피부 속으로 신속하고 고르게 전달되기 위한 목적으로 애완견 미용 및 상처 치료용으로 무기재료가 혼입된 애완견용 하이드로겔 패치 및 그 제조방법을 제공하고자 한다. In this regard, the hydrogel patch for pets mixed with the inorganic material of the present invention can be dissolved slowly, and the pet dog mixed with inorganic materials for the treatment of beauty and wounds for the purpose of dogs can be quickly and evenly delivered to the skin. To provide a hydrogel patch and a method for producing the same.
본 발명의 일 견지에 의하면,According to one aspect of the invention,
폴리비닐알코올(PVA), 폴리에틸렌글리콜(PEG), 폴리에틸렌옥사이드(PEO), 폴리비닐아크릴산(PVAc), 및 폴리메타아크릴산(PMAc)으로 구성된 그룹으로부터 선택된 적어도 하나의 합성 고분자 물질 0.1-90중량%과 콜라겐, 젤라틴, 아가, 카라기난, 알기네이트, 키토산, 키토산 유도체, 전분 풀루란, 갈락토만난, 글루코만난, 구아검, 로카스트빈검, 플루로닉, 알긴, 엘라스틴, 풀로테오글루칸, PLA, PGA, PLGA, 잔탄 및 겔란으로 구성된 그룹으로부터 선택된 적어도 하나의 천연 고분자 물질 0.1-90중량% 로 구성된 하이드로겔이 이용될 수 있다. 0.1-90% by weight of at least one synthetic polymeric material selected from the group consisting of polyvinyl alcohol (PVA), polyethylene glycol (PEG), polyethylene oxide (PEO), polyvinyl acrylic acid (PVAc), and polymethacrylic acid (PMAc); Collagen, gelatin, agar, carrageenan, alginate, chitosan, chitosan derivatives, starch pullulan, galactomannan, glucomannan, guar gum, locust bean gum, pluronic, algin, elastin, pulloteoglucan, PLA, PGA, PLGA Hydrogels composed of 0.1-90% by weight of at least one natural polymeric material selected from the group consisting of xanthan and gellan may be used.
피부의 트러블을 효과적으로 관리하기 위해서는 피부친화적인 천연소재를 사용 한다. 천연소재로는 세라마이드, 코직산, a-히드록시산 및 히드록시산, 레티놀, 비타민 C, 비타민 C유도체, 비타민 A, 비타민 E, 아미노산, 구아바, 포도씨앗 추출물, 카모마일, 히알루로닉산, 어성초, 도인, 도인피, 파란근, 리기다, 상황, 영지버섯, 신이화, 포공영, 율피, 동백유, 피톤치드, 버드나무, 자작나무, 소나무추출물, 감자, 감초, 고삼, 갈조, 굴, 그레이프씨드, 꿀, 녹차, 당근, 당약, 들국화, 딸기 로즈마리, 마카데미아넛 오일, 마트리카리아, 비피두스, 사플로워오일, 상백피, 세이지, 수세미, 식물성 스쿠알렌, 세리신, 피브로인, 아카시아. 쌀, 쑥, 아몬드오일, 아보카도오일, 아이비, 알로에, 옥수수, 올리브오일, 우유단백질, 울금, 유용성감초, 인삼, 작약, 장미, 창포, 천궁, 치자, 코코넛오일, 파슬리, 헨나, 호스테일, 호호바오일, 황토 등으로부터 최소 하나 또는 둘 이상 사용가능하고, 항상화, 항균성, 항염증성, 항세포독성, 항자극성, 항알러지성, 보습성, 미백효과, 수렴효과, 진정효과 등을 부여할 수 있는데, 0.1중량% 내지 30중량% 사이의 함량을 갖는 것을 특징으로 한다. 이것은 0.1중량%이하의 경우 효능이 미비하여 30중량%이상의 경우 추출물의 고유적인 색소가 전체의 제품에 영향을 미칠 수 있는 단점을 가지고 있다. In order to effectively manage skin troubles, skin-friendly natural materials are used. Natural materials include ceramide, kojic acid, a-hydroxy acid and Hydroxy acids, retinol, vitamin C, vitamin C derivatives, vitamin A, vitamin E, amino acids, guava, grapeseed extract, chamomile, hyaluronic acid, effervescent, cabbage, cabbage, blue root, rigida, situation, ganoderma lucidum, Shin Ehwa, Pogongyoung, Yulpi, Camellia Oil, Phytoncide, Willow, Birch, Pine Extract, Potato, Licorice, Red Ginseng, Brown Sea, Oyster, Grape Seed, Honey, Green Tea, Carrot, Sugar, Wild Chrysanthemum, Strawberry Rosemary, Macadamia Nut Oil , Matricaria, Bifidus, Saffron Oil, Morus, Sage, Scrubber, Vegetable Squalene, Sericin, Fibroin, Acacia. Rice, mugwort, almond oil, avocado oil, ivy, aloe, corn, olive oil, milk protein, turmeric, useful licorice, ginseng, peony, rose, iris, celery, gardenia, coconut oil, parsley, henna, hostile, jojoba It can be used at least one or two from oil, ocher, etc., it can give homeostasis, antimicrobial, anti-inflammatory, anti-cytotoxic, anti-irritant, anti-allergic, moisturizing, whitening, astringent, calming effect, etc. It is characterized by having a content between 0.1% to 30% by weight. This is less than 0.1% by weight of the efficacy is less than 30% by weight has a disadvantage that the intrinsic pigment of the extract can affect the whole product.
기능성을 부여할 수 있는 무기재료로는 MMT, Nano Ag, Au, SiO2, TiO2, ZnO, CdS 등의 재료중 선택된 적어도 하나의 물질이 0.01-30중량% 함유된 하이드로겔 패치가 제공될 수 있다.Inorganic materials capable of imparting functionality may be provided with hydrogel patches containing 0.01-30% by weight of at least one material selected from materials such as MMT, Nano Ag, Au, SiO 2 , TiO 2 , ZnO, CdS, and the like. have.
본 발명의 용해가 가능한 무기재료가 혼입된 하이드로겔은 애완견 미용 및 상처의 치유를 촉진시키고, 상처를 입기 전의 상태로 가능한 가깝게 되돌려 상처로 인한 아픔을 줄이고, 심한 흉터가 생기는 것을 방지하기 위한 제제로서, 상처가 난 후 초기에 상처 부위를 압박하여 지혈을 할 수 있으며, 유효성분이 서서히 방출되어 상처의 치유를 촉진시키고, 손상된 피부의 재생을 도와주며, 상처치유과정에서 피부의 재생이 가급적 빠르게 이루어지게 하여 흉터가 생기지 않게 도와주는 상처 치료 및 애완견 미용에 사용되는 제제를 제공하며, 피부 접착 시 완전히 용해되어 유효성분들이 피부로 침투되는 무기재료가 혼입된 하이드겔을 제공하는 것이다.Hydrogel incorporating the soluble inorganic material of the present invention promotes the healing of dogs and wounds, as close as possible to the state before the wound to reduce the pain caused by the wound, as a preparation for preventing severe scars In the early stage of wound healing, hemostasis can be performed by compressing the wound area, and the active ingredient is slowly released to promote healing of the wound, to help rejuvenate the damaged skin, and to regenerate the skin as soon as possible during the wound healing process. It provides a formulation used for wound treatment and pet dog grooming to help prevent scars, and to provide a hydrogel containing inorganic materials that are completely dissolved when the skin adheres to the active ingredients penetrated into the skin.
본 발명의 무기재료가 혼입된 하이드로겔은 상처 치료 및 애완견 미용에 획기적으로 치료할 수 있는 제제의 형태로서, 세부적으로는 상처치료용, 흉터 제거, 밴드 등에 효과적으로 활용될 수 있다.
Hydrogel incorporating the inorganic material of the present invention is in the form of a formulation that can be curatively treated for wound treatment and dog grooming, in detail can be effectively used for wound treatment, scar removal, bands and the like.
본 발명의 애완견 미용 및 상처치료용 무기재료가 혼입된 하이드로겔 패치는 피부치료 및 미용제를 함유한 하이드로겔로서 피부에 부착 시 용해가 가능하게 되어 피부 트러블 증진제 및 모의 위생관리를 향상시킬 수 있는 약제 등 다량의 유효성분이 피부 속으로 신속하게 전달 될 수 있는 것을 특징으로 한다. The hydrogel patch containing the inorganic material for pet dog beauty and wound treatment of the present invention is a hydrogel containing a skin treatment and a beauty agent that can be dissolved when attached to the skin to improve the skin trouble enhancer and mock hygiene management. It is characterized in that a large amount of active ingredients such as drugs can be quickly delivered into the skin.
본 발명의 무기재료가 혼입된 하이드로겔은 애완견 미용, 모의 위생관리 및 상처치료용 패치로 제조되어 피부에 부착 시 서서히 용해됨으로서 애완견 미용제나 상처치료제와 같은 유효성분이 피부로 잘 전달되게 하는 특성이 있으며, 또한 하이드로겔 내에는 무기재료 및 유효성분이 피부전달을 증진시키는 천연 친화성 증진제가 함유되어 있어서 만족할 만한 양의 유효성분이 신속하게 경피 속으로 전달될 수 있는 특징을 갖고 있다. 그러므로 본 발명에서의 무기재료가 혼입된 하이드로겔은 피부에 접촉 시 피부에 존재하는 소량의 수분에 의해 용해되어 수용액상태로 변화하는 것을 특징으로 하는 신규의 애완견 미용 및 상처치료용 하이드로겔 패치를 제공하는 것이다. The hydrogel mixed with the inorganic material of the present invention is manufactured as a patch for dog beauty, mock hygiene management and wound treatment, so that it gradually dissolves when attached to the skin, so that an active ingredient such as a dog beauty agent or wound treatment agent is well delivered to the skin. In addition, the hydrogel contains a natural affinity enhancer that enhances skin transfer of inorganic materials and active ingredients, so that a satisfactory amount of active ingredients can be rapidly delivered into the percutaneous skin. Therefore, the hydrogel in which the inorganic material is mixed in the present invention is dissolved by a small amount of moisture present in the skin and thus provides a novel hydrogel patch for grooming and wound treatment, characterized in that it changes to an aqueous solution state. It is.
합성고분자, 천연고분자 및 유효 천연 약제등의 복합 조성물을 고농도로 제조하여 동결해동법(Freezing-thawing method)을 이용하여 시트 및 패치 형태로 제조할 수 있다. 특히, 동결해동법으로 시트 및 패치 형태 제조시 동결온도를 영하 70도에서 영하 1도로 조절하거나, 해동온도를 영상 1도에서 영상 50도로 조절함으로서 시트 및 패치의 수용화 정도를 조절 할 수 있다는 것을 발견하여 본 발명을 완성할 수 있었다. Composite compositions such as synthetic polymers, natural polymers, and effective natural drugs can be prepared in high concentrations and prepared in the form of sheets and patches using the freezing-thawing method. In particular, it was found that the degree of receptivity of the sheets and patches can be controlled by adjusting the freezing temperature by adjusting the freezing temperature from minus 70 degrees to minus 1 degree or by adjusting the thawing temperature from 1 degree to 50 degrees when freezing and thawing were produced. It was possible to complete the present invention.
본 발명의 무기재료가 혼입된 하이드로겔 조성물은 시트(sheet) 또는 패치(patch)가 피부에 적용되어 밀착 되었을 때 하이드로겔 상태가 용해됨으로서 조성물과 피부사이의 친화성을 최적으로 향상시켜서 애완견 미용제가 피부로 잘 전달되게 하는 특성이 있으며, 또 조성물 속에 피부의 세균을 제거시켜주는 무기재료가 혼입되어 있어서 만족할만한 효과를 신속하게 얻을 수 있는 특징이 있다. 그러므로 본 발명에서 무기재료가 혼입된 하이드로겔은 급격하게 유동상태로 변화하는 것을 특징으로 하는 신규의 무기재료가 혼입된 하이드로겔 조성물을 제공한다. The hydrogel composition in which the inorganic material of the present invention is mixed is dissolved in the hydrogel state when the sheet or patch is applied to the skin, thereby improving the affinity between the composition and the skin, thereby providing a pet dog beauty agent. There is a characteristic to be well delivered to the skin, and also has an inorganic material that removes the bacteria of the skin in the composition is characterized in that it can quickly obtain a satisfactory effect. Therefore, the present invention provides a hydrogel composition incorporating a new inorganic material, characterized in that the hydrogel in which the inorganic material is incorporated changes rapidly in a fluid state.
본 발명의 무기재료가 혼입된 하이드로겔은 고상의 상태가 피부의 영향에 의해 액상인 유동상태(liquid state)로 변화하는 물리적인 특성을 가지고 있다. 특히, 애완견 미용의 용도로 사용될 때에 본 발명의 무기재료가 혼입된 하이드로겔 시트(sheet) 또는 패치(patch) 형태의 제품을 피부에 부착시키면 유동상태로 변화를 일으켜서 흐름성이 있는 조성물로 변화하게 되며, 이는 피부에 자동적으로 밀착, 침투 되면서 피부와의 친화성을 크게 향상시키는 특징을 갖는다. Hydrogel incorporating the inorganic material of the present invention has a physical property that the solid state changes to a liquid state (liquid state) by the influence of the skin. In particular, when used in the application of pet dog grooming products in the form of a hydrogel sheet (sheet) or patch (patch) incorporating the inorganic material of the present invention to the skin to change the flow state to change to a flowable composition It is a feature that greatly enhances the affinity with the skin while being in close contact with the skin automatically.
이와 같이 제조된 본 발명의 무기재료가 혼입된 하이드로겔은 피부 접촉 시 수분에 의해 서서히 용해되어 유효성분들이 피부로 침투되므로 상처의 치유를 촉진시키고, 상처를 입기전의 상태로 가능한 가깝게 되돌려서 상처로 인한 아픔을 줄이고, 심한 흉터가 생기는 것을 방지하기 위한 제제로서, 상처가 난 후 초기에 상처 부위를 무기재료가 혼입된 하이드로겔로 압박하여 지혈 할 수 있으며, 유효성분이 서서히 방출되어 상처의 치유를 촉진시키고, 손상된 피부의 재생을 도와주며, 상처치유과정에서 피부의 재생이 가급적 빠르게 이루어지게 하여 흉터가 생기지 않게 도와주는 상처 치료 및 애완견 미용에 사용된다. 뿐만 아니라, 본 발명의 무기재료가 혼입된 하이드로겔은 애완견 미용, 모의 위생적 관리, 흉터제거, 밴드 등에 이용될 수 있다. The hydrogel incorporating the inorganic material of the present invention prepared as described above is gradually dissolved by moisture when the skin is in contact, so that the active ingredients penetrate the skin, thereby promoting the healing of the wound, and returning it as close as possible to the wound before the wound. It is a preparation to reduce the pain caused and to prevent severe scars, and it is possible to bleed the wound area by pressing hydrogel with inorganic material in the early stage after the wound, and the active ingredient is gradually released to promote wound healing. It helps to regenerate damaged skin, and to regenerate the skin as soon as possible during wound healing, and is used for wound treatment and dog grooming to help prevent scars. In addition, the hydrogel incorporating the inorganic material of the present invention can be used for dog grooming, mock hygiene management, scar removal, bands and the like.
실시예1-7(무기재료가 혼입된 하이드로겔 제조)Example 1-7 (Preparation of Hydrogel with Inorganic Materials)
상온에서 1L 용기에 교반하면서 하기 표 1에 타나난 바와 같이 각 성분을 혼합 하였다. 먼저 탈이온수에 합성고분자 물질을 첨가하고 70로 승온한 후 천천히 교반시키면서 완전히 용해시킨 후 상온에서 천연고분자 물질과 피부친화적 천연물을 나중에 첨가하였다. Each component was mixed as shown in Table 1 while stirring in a 1 L container at room temperature. First, the synthetic polymer material was added to deionized water, the temperature was raised to 70, and then completely dissolved under slow stirring. Then, the natural polymer material and the skin-friendly natural product were added later at room temperature.
그 다음 영하 30도와 영상 10도에 동결해동법을 통하여 패치 형태의 겔을 성형시켰다. Then, the gel in the form of a patch was formed through freeze thaw at minus 30 degrees and image 10 degrees.
(폴리비닐알코올)PVA
(Polyvinyl alcohol)
실시예 8 - 용해도 실험Example 8-Solubility Experiments
실시예 1-7과 같은 방법으로 제조된 무기재료가 혼입된 하이드로겔은 무게에 대한 물의 함량을 0, 1, 5, 10, 20, 50%로 변화시켜 용해성 정도를 측정하였다. 그 결과를 표 2에 나타내었다. Hydrogel containing the inorganic material prepared in the same manner as in Example 1-7 was measured by varying the water content to 0, 1, 5, 10, 20, 50% by weight of the solubility. The results are shown in Table 2.
실험결과 수분이 없을 경우 무기재료가 혼입된 하이드로겔은 전혀 용해되지 않았지만 무게에 대한 1-5%의 수분으로도 용해되었다. 따라서 본 발명의 무기재료가 혼입된 하이드로겔은 1-5%의 소량의 수분으로도 충분히 용해성을 나타냄을 알 수 있었다.In the absence of moisture, the hydrogel containing the inorganic material was not dissolved at all, but was dissolved in water of 1-5% by weight. Therefore, it was found that the hydrogel mixed with the inorganic material of the present invention was sufficiently soluble even with a small amount of water of 1-5%.
(X; 용해되지 않음, ;일부 용해됨, O;완전 용해됨)(X; not soluble, ; Some dissolved, O; fully dissolved)
실시예 9 - 세포활성시험Example 9-Cell Activity Test
상기 실시예 1로 제조한 무기재료가 혼입된 하이드로겔 위에 macrophage Raw 264.7 cells의 세포활성 시험을 실시하였다. T-bottle에 세포를 분주한 후, 80%의 confluency에 도달 할 때 serum free EMEM으로 교체하였다. 6 well plate에 제조한 무기재료가 혼입된 하이드로겔을 넣고, macrophage Raw 264.7 cells을 5X104 cells/well의 세포를 분주한 후 24시간, 48시간 세포활성을 측정하였다. 위와 같은 방법으로 측정한 결과 24시간 이후 48시간째 세포배양이 2-4배 가까이 증가한 것으로 보아 세포활성이 우수한 것을 알 수 있었다. Cellular activity test of macrophage Raw 264.7 cells was performed on the hydrogel containing the inorganic material prepared in Example 1 above. After dispensing cells into the T-bottle, the cells were replaced with serum free EMEM when reaching 80% confluency. Hydrogel containing the prepared inorganic material was added to a 6 well plate, and macrophage Raw 264.7 cells were divided into cells of 5 × 10 4 cells / well, and then cell activities were measured for 24 hours and 48 hours. As a result of the measurement as described above, the cell culture was increased by 2-4 times after 48 hours and the cell activity was excellent.
실시예 10- 항균성 시험Example 10 Antibacterial Test
실시예 1로 제조된 본 발명의 무기재료가 혼입된 하이드로겔을 섬유시험연구소(FITI)에 의뢰하여, 항균도 시험방법((FC-TM-20)-2001))으로 항균성 시험을 수행하였다. 그 결과를 하기 표에 나타내었다 (본 발명의 피부 접착 시 용해가 가능한 무기재료가 혼입된 하이드로겔은 실시 예 1의 피부 접착 시 용해가 가능한 하이드로겔을 제조하고 충분히 컨디셔닝 시켜 준비됨).The hydrogel incorporating the inorganic material of the present invention prepared in Example 1 was commissioned to the Textile Testing Laboratory (FITI), and the antimicrobial test was performed by the antimicrobial test method ((FC-TM-20) -2001). The results are shown in the table below (the hydrogel in which the inorganic material soluble in the skin adhesion of the present invention is mixed is prepared by preparing a soluble hydrogel in the skin adhesion of Example 1 and conditioning sufficiently).
항균가공제품과 대조편에 공시 균을 접종하여 배양한 후, 생균수를 측정하여, 항균가공제품(가공포)과 대조편(표준포)을 비교함으로서 균의 성장을 억제하는 활성도(정균감소율)는 다음과 같은 식 1에 의해 계산된다. After inoculating the inoculated microorganisms on the antimicrobial processed product and the control piece, the number of viable cells was measured, and the activity of inhibiting the growth of the bacteria by comparing the antimicrobial processed product (processed fabric) and the control piece (standard fabric) (microbial reduction rate) Is calculated by the following equation.
정균감소율% = (C-B)/CX100Reduction of bacteriostatic percentage = (C-B) / CX100
(B=가공포의 배양 후 균수, C=표준포의 배향 후 균수)
(B = number of bacteria after culture of processed cloth, C = number of bacteria after orientation of standard cloth)
(31.6배 이상)105 times increase
(More than 31.6 times)
(31.6배 이상)200x increase
(More than 31.6 times)
공시균: 1) 스타필로코커스 아우레우스(Staphylococcus aureus) ATCC 6538Test bacteria: 1) Staphylococcus aureus ATCC 6538
2) 클렙시엘라 뉴모니아(Klebsiella pneumoniae) ATCC 43522) Klebsiella pneumoniae ) ATCC 4352
상기 표에 나타낸 바와 같이, 본 발명의 용해가 가능한 무기재료가 혼입된 하이드로겔은 스타필로코커스 아우레우스(Staphylococcus aureus) 및 클렙시엘라 뉴모니아(Klebsiella pneumoniae)에 대하여 모두 99.9% 이상의 정균율을 나타내어 매우 우수한 항균성을 가짐을 알 수 있다. As shown in the above table, the hydrogel containing the soluble inorganic material of the present invention has a bacteriostatic rate of 99.9% or more for Staphylococcus aureus and Klebsiella pneumoniae . It can be seen that it has a very good antibacterial properties.
Claims (4)
0.1-90% by weight of synthetic polymers, 0.1-90% by weight of natural polymers, 0.1-30% by weight of skin-friendly natural active ingredients, inorganic materials0.01- 1, based on the total weight of the composition 30% by weight, prepared by freezing and thawing sheet and patch form prepared by adjusting the freezing temperature from minus 70 degrees to minus 1 degree, or thawing temperature is repeated once or 20 times from image 1 to 50 degrees Sheets and patches and methods of manufacturing them
The polymer according to claim 1, wherein the polymer capable of forming the hydrogel in which the inorganic material is incorporated is polyvinyl alcohol (PVA), polyethylene glycol (PEG), polyethylene oxide (PEO), polyvinyl acrylic acid (PVAc), and polymetha. 0.1-90% by weight of at least one synthetic polymeric material selected from the group consisting of acrylic acid (PMAc) and collagen, gelatin, agar, carrageenan, alginate, chitosan, chitosan derivatives, starch pullulan, galactomannan, glucomannan, guar gum, Hydrogel sheets and patches composed of 0.1-90% by weight of at least one natural polymeric material selected from the group consisting of locust bean gum, pluronic, algin, elastin, pulloteoglucan, PLA, PGA, PLGA, xanthan and gellan
According to claim 1, Hydrogel sheet and patch consisting of at least one or more selected from among materials such as MMT, Nano Ag, Au, SiO 2 , TiO 2 , ZnO, CdS of the inorganic material
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100033697A KR20110114195A (en) | 2010-04-13 | 2010-04-13 | Pet hydrogel patch mixed with inorganic materials and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100033697A KR20110114195A (en) | 2010-04-13 | 2010-04-13 | Pet hydrogel patch mixed with inorganic materials and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110114195A true KR20110114195A (en) | 2011-10-19 |
Family
ID=45029324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100033697A Ceased KR20110114195A (en) | 2010-04-13 | 2010-04-13 | Pet hydrogel patch mixed with inorganic materials and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110114195A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014001932A1 (en) * | 2012-06-27 | 2014-01-03 | Dsm Ip Assets B.V. | Nanogel comprising water-soluble active ingredients |
CN103908693A (en) * | 2014-04-15 | 2014-07-09 | 山东颐诺生物科技有限公司 | Bionic alginate composite antimicrobial dressing and preparation method thereof |
CN104394715A (en) * | 2012-06-27 | 2015-03-04 | 帝斯曼知识产权资产管理有限公司 | Nanogel comprising water-soluble active ingredients |
CN104815350A (en) * | 2015-04-16 | 2015-08-05 | 福州百正医药科技有限公司 | Tremella polysaccharide dressing and preparing method of product of tremella polysaccharide dressing |
CN105536032A (en) * | 2015-12-16 | 2016-05-04 | 辽东学院 | Preparation method of nanofiber antimicrobial dressing blended from nano-silver containing sericin and polyoxyethylene |
WO2017051934A1 (en) * | 2015-09-24 | 2017-03-30 | Kim Son Sil | Bio nano gold polysaccharide colloidal solution and its method of production |
KR20200000092A (en) * | 2018-06-22 | 2020-01-02 | 한국해양과학기술원 | Hydrogel for Skin Regeneration Comprising Stichopus japonicus Hydrolysates, and Fabricating Thereof |
KR20200073035A (en) * | 2018-12-13 | 2020-06-23 | (주)지엘 | Hot pack Coated Hydrogel with Mugwort Extract |
KR20220068372A (en) * | 2020-11-19 | 2022-05-26 | 가톨릭관동대학교산학협력단 | Patch for preventing allergy |
WO2023101061A1 (en) * | 2021-12-03 | 2023-06-08 | 가톨릭관동대학교산학협력단 | Patch for allergy prevention |
CN119055562A (en) * | 2024-11-06 | 2024-12-03 | 北京和益源生物技术有限公司 | A natural skin care hydrogel for pet wounds and its preparation method and application |
-
2010
- 2010-04-13 KR KR1020100033697A patent/KR20110114195A/en not_active Ceased
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9661870B2 (en) | 2012-06-27 | 2017-05-30 | Dsm Ip Assets B.V. | Nanogel comprising water-soluble active ingredients |
CN104394715A (en) * | 2012-06-27 | 2015-03-04 | 帝斯曼知识产权资产管理有限公司 | Nanogel comprising water-soluble active ingredients |
WO2014001932A1 (en) * | 2012-06-27 | 2014-01-03 | Dsm Ip Assets B.V. | Nanogel comprising water-soluble active ingredients |
CN103908693A (en) * | 2014-04-15 | 2014-07-09 | 山东颐诺生物科技有限公司 | Bionic alginate composite antimicrobial dressing and preparation method thereof |
CN104815350A (en) * | 2015-04-16 | 2015-08-05 | 福州百正医药科技有限公司 | Tremella polysaccharide dressing and preparing method of product of tremella polysaccharide dressing |
WO2017051934A1 (en) * | 2015-09-24 | 2017-03-30 | Kim Son Sil | Bio nano gold polysaccharide colloidal solution and its method of production |
CN108024958A (en) * | 2015-09-24 | 2018-05-11 | 金善实 | Biological nano gold Polysaccharide solution and its manufacture method |
CN105536032A (en) * | 2015-12-16 | 2016-05-04 | 辽东学院 | Preparation method of nanofiber antimicrobial dressing blended from nano-silver containing sericin and polyoxyethylene |
KR20200000092A (en) * | 2018-06-22 | 2020-01-02 | 한국해양과학기술원 | Hydrogel for Skin Regeneration Comprising Stichopus japonicus Hydrolysates, and Fabricating Thereof |
KR20200073035A (en) * | 2018-12-13 | 2020-06-23 | (주)지엘 | Hot pack Coated Hydrogel with Mugwort Extract |
KR20220068372A (en) * | 2020-11-19 | 2022-05-26 | 가톨릭관동대학교산학협력단 | Patch for preventing allergy |
WO2023101061A1 (en) * | 2021-12-03 | 2023-06-08 | 가톨릭관동대학교산학협력단 | Patch for allergy prevention |
CN119055562A (en) * | 2024-11-06 | 2024-12-03 | 北京和益源生物技术有限公司 | A natural skin care hydrogel for pet wounds and its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110114195A (en) | Pet hydrogel patch mixed with inorganic materials and its manufacturing method | |
Aljghami et al. | Emerging innovative wound dressings | |
Rezvani Ghomi et al. | Wound dressings: Current advances and future directions | |
KR20090027838A (en) | Moisture sensitive fibrids composition and preparation method thereof | |
EP3672655B1 (en) | Biomaterial and methods of making and using said biomaterial | |
Chopra et al. | Strategies and therapies for wound healing: a review | |
KR100676937B1 (en) | Water-soluble film for skin care and wound treatment and method of manufacturing the same | |
Li et al. | Antibacterial strategies for wound dressing: preventing infection and stimulating healing | |
RU2422133C1 (en) | Hydrophylic gel, method of its obtaining (versions), wound covering and based on it bandage means | |
Cao et al. | Antibacterial and antioxidant wound dressings with pH responsive release properties accelerate chronic wound healing | |
CN101249274A (en) | Preparation and application of bletilla striata polysaccharide hydrogel for promoting wound healing | |
TWI600438B (en) | Method of hydrogel sheet for wound | |
CN104383585B (en) | A kind of three-dimensional manometer composite adhesive bandage and preparation and application thereof | |
Rashdan et al. | Traditional and modern wound dressings—characteristics of ideal wound dressings | |
CN103480032A (en) | Silver-containing composite gel dressing and preparation method thereof | |
Ndlovu et al. | Cellulose acetate-based wound dressings loaded with bioactive agents: Potential scaffolds for wound dressing and skin regeneration | |
Sonar et al. | A comprehensive review on wound dressing usage in clinical settings | |
US8303980B2 (en) | Wound-dressing material and method for manufacturing the same | |
Pallikkunnel et al. | Alginate-Based Wound-Healing Dressings | |
KR200340228Y1 (en) | Wound covering material produced from a Foam dressing using a Neutralized Chitosan foam dressing | |
Rajwade et al. | Wound treatment using nanomaterials | |
KR20090034173A (en) | Silk dressing material | |
Kumar et al. | New frontiers in wound-dressings: An interdisciplinary perspective | |
CN117959479B (en) | Preparation method of three-dimensional traditional Chinese medicine dressing for treating pressure sores and three-dimensional traditional Chinese medicine dressing prepared by preparation method | |
Mittal et al. | 17 Bionanomaterials in Wound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20100413 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20111211 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20120726 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20111211 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |